Written by Steven Hansen
The U.S. new cases 7-day rolling average are 12.4 % LOWER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 0.6 % LOWER than the rolling average one week ago. Today’s posts include:
- U.S. Coronavirus New Cases are 47,325
- U.S. Coronavirus deaths are at 818
- U.S. Coronavirus immunizations have been administered to 74.6 doses per 100 people.
- The 7-day rolling average rate of growth of the pandemic shows new cases improved and deaths improved
- Norwegian Cruise Line CEO says U.S. ships are unlikely to sail this summer, calls CDC guidance ‘unfair’
- Evolutionary Guesstimates on B.1.617 [the Indian variant]
- Immunosuppression in COVID-19 promotes emergence of multiple immune escape mutants
- India cases hit new record as calls grow for strict lockdown
- India’s Richest Man Retools Factories to Provide FREE Oxygen to 1 in 10 COVID Patients Across Country
- Here’s how the pandemic has affected India
- New Study Estimates More Than 900,000 People Have Died Of COVID-19 In U.S
- Global COVID-19 death toll more than double the estimates
- In a sign of flagging demand, only 9 percent of American adults have not been vaccinated and say they would like to get a shot as soon as possible
include($_SERVER[‘DOCUMENT_ROOT’].’/pages/coronavirus1.htm’); ?>
Hospitalizations Are The Only Accurate Gauge
Hospitalizations historically appear to be little affected by weekends or holidays. The hospitalization growth rate trend continues to improve.
source: https://gis.cdc.gov/grasp/covidnet/COVID19_3.html
Historically, hospitalization growth follows new case growth by one to two weeks.
As an analyst, I use the rate of growth to determine the trend. But, the size of the pandemic is growing in terms of real numbers – and if the rate of growth does not become negative – the pandemic will overwhelm all resources.
The graph below shows the rate of growth relative to the growth a week earlier updated through today [note that negative numbers mean the rolling averages are LOWER than the rolling averages one week ago]. As one can see, the rate of growth for new cases peaked in early December 2020 for Thanksgiving, and early January 2021 for end-of-year holidays – and it now shows that the coronavirus effect is improving.
In the scheme of things, new cases decline first, followed by hospitalizations, and then deaths. The potential fourth wave did not materialize likely due to immunizations.
Coronavirus News You May Have Missed
- With eligibility for COVID-19 vaccination now open to all adults in the U.S., the latest KFF COVID-19 Vaccine Monitor shows that while the pace of vaccine uptake has continued rapidly over the past month, enthusiasm may be reaching a plateau. The share of adults who say they’ve gotten at least one dose of a vaccine or intend to do so as soon as possible inched up from 61% in March to 64% in April, while the share who want to “wait and see” before getting vaccinated – a group that had been steadily decreasing in size since over several months – remained about the same in April (15%) compared to March (17%). Among Republicans, a group that has been slower to embrace the vaccine, over half now say they’ve gotten at least one dose or will do so as soon as they can. The share of Republicans who say they will “definitely not” get vaccinated decreased from 29% in March to 20% in April but remains substantially larger than the share among Democrats or independents.
- In the wake of news about blood clots possibly linked to the Johnson & Johnson COVID-19 vaccine and the subsequent pause in the use of this vaccine, less than half the public expresses confidence in the safety of the Johnson & Johnson vaccine, and concerns about potential side effects have increased among those not yet vaccinated, especially women. Hispanic women are particularly likely to say that the news of these blood clots caused them to rethink their vaccination decision. Despite this, the trajectory of vaccine uptake and enthusiasm does not appear to have slowed disproportionately among women over the past month. Two-thirds (66%) of women say they’ve been vaccinated or will do so as soon as possible, compared to 63% of men.
- Among those who are open to getting vaccinated but have not yet tried to get an appointment, reasons range from safety concerns to logistical barriers to questions about eligibility, and vary widely by vaccination intention. Those who say they want the vaccine as soon as possible mainly cite logistical concerns and information needs; those in the wait and see group mainly express safety concerns or a lack of research, and those who say they’ll get the vaccine only if required mainly say they don’t feel they want or need the vaccine. By contrast, when those who say they will “definitely not” get vaccinated are asked if there is anything that might change their mind, the answer is a resounding “no.”
- While side effects and safety top the list of concerns for those who haven’t gotten vaccinated for COVID-19, we continue to find that lack of information and access are barriers for some individuals, particularly people of color. For example, Black and Hispanic adults are more likely than White adults to be concerned about having to miss work due to side effects, having to pay out-of-pocket for the COVID-19 vaccine (even though it is free), or not being able to get the vaccine from a place they trust. In addition, 45% of Hispanic adults say they don’t have enough information about when they can get vaccinated and a similar share are not sure whether they are currently eligible to receive the vaccine in their state (even though eligibility is now open to all U.S. residents).
- About half of young adults ages 18-29 say they’ve already gotten at least one dose of a COVID-19 vaccine or will do so as soon as possible, but about a quarter say they still want to “wait and see” how the vaccine is working, higher than any other age group. Peer networks may play a role in encouraging vaccine uptake among young adults; those who say at least half of their close friends are vaccinated are much more enthusiastic about getting vaccinated themselves compared to those who say just a few or none of their friends have gotten a shot. In addition, young adults may be more receptive than older adults to vaccination requirements in order to travel or attend large gatherings.
- As the U.S. awaits authorization of a COVID-19 vaccine for use in children under age 16, three in ten parents of children ages 12-15 say they will get their child vaccinated as soon as a vaccine is available, one quarter say they will wait a while to see how the vaccine is working, 18% plan to get their child vaccinated if their school requires it, and nearly a quarter say they will definitely not get their child vaccinated. Perhaps unsurprisingly, parents’ intentions for vaccinating their kids largely line up with their own intentions for getting the COVID-19 vaccine themselves.
India cases hit new record as calls grow for strict lockdown – AP
With coronavirus cases surging to record levels, Indian Prime Minister Narendra Modi is facing growing pressure to impose a harsh nationwide lockdown amid a debate whether restrictions imposed by individual states are enough.
Many medical experts, opposition leaders and some of the Supreme Court judges have suggested the lockdown seems to be the only option with the virus raging in cities and towns, where hospitals are forced to turn patients away while relatives scramble to find oxygen. Crematoriums and burial grounds are struggling to handle the dead.
On Friday, India recorded a new record of 414,188 confirmed cases in the past 24 hours, Its tally has risen to more than 21.4 million since the pandemic began with faint hopes of the curve going down quickly. The Health Ministry also reported 3,915 additional deaths, bringing the total to 234,083. Experts believe both figures are an undercount.
Evolutionary Guesstimates on B.1.617 – MedPage
The new B.1.617 variant in India contains some of these key mutations. Along with D614G and L452R, it contains a mutation called E484Q, which is similar to the E484K mutation found in the variants from South Africa and Brazil. And, it contains a mutation called P681R, similar to the P681H mutation in the U.K. variant.
Like other variants that have emerged during the pandemic, B.1.617 actually has many other mutations, about 20-30 total mutations depending on the subtype. The first report of this variant in the GISAID occurred way back in October 2020.
Balloux thinks that the “jury is still out” on whether B.1.617 is more transmissible or more virulent. It could just be that it was in the right place at the right time: a lot of other variants are also circulating in India, cases have increased dramatically, and this variant could just be hitchhiking along.
“It’s intriguing that B.1.617 took so long to really take off properly. Sure, it’s going up in frequency because there’s lots of transmission in India, but I don’t have the impression it’s going up faster,” he said. “If you have an outbreak, cases go up. If by chance there’s a viral lineage in the local area, it becomes more frequent, not always because it has an intrinsic advantage.”
Based on the fact that the B.1.617.2 (a subtype that has spread most often in the U.K. and seems to be frequent in India) has lost the E484Q mutation, Balloux anticipates that this variant will “not become particularly widespread globally.”
“I don’t think that it will take over the world. I’m actually not even convinced that it will be considered a variant of interest in the future,” he said.
But preliminary modelling by the World Health Organization (WHO) suggests that B.1.617 may have higher growth rates than other variants that are circulating in India, suggesting increased transmissibility. The WHO adds that other circulating variants as well as human factors, such as lack of adherence to public health measures and mass gatherings during celebrations and elections, may have contributed to the epidemic.
While Sahoo thinks that B.1.617 could be “one of the drivers” of the epidemic in India, the other important cause is the “false presumption that the exponential phase was over, and returning to normalcy sooner, particularly in the megacities.” Based on key mutations that could increase infectivity, Sahoo anticipates that B.1.617 could “potentially outcompete the U.K. strain,” but that’s less likely if India gets its cases under control in the next 2 months.
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19 – American Journal of Therapeutics
A large majority of randomized and observational controlled trials of ivermectin are reporting repeated, large magnitude improvements in clinical outcomes. Numerous prophylaxis trials demonstrate that regular ivermectin use leads to large reductions in transmission. Multiple, large “natural experiments” occurred in regions that initiated “ivermectin distribution” campaigns followed by tight, reproducible, temporally associated decreases in case counts and case fatality rates compared with nearby regions without such campaigns.
Conclusions:
Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance. Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.
Global COVID-19 death toll more than double the estimates: study – Aljazeera
The COVID-19 pandemic has caused nearly 6.9 million deaths across the world, more than double the number officially recorded, a new analysis from the University of Washington, DC’s Institute for Health Metrics and Evaluation (IHME) estimated.
Deaths go unreported as most countries only record those that occur in hospitals or of patients with a confirmed infection, the report which came out on Thursday, revealed.
Current reported estimates showed more than 155 million infections worldwide with at least 3.25 million deaths, according to Johns Hopkins University data.
The IHME is an independent health research organisation that provides a comparable measurement of the world’s health problems and has been cited in the past by the White House and its reports are watched closely by public health officials.
The reported COVID-19 mortality is strongly related to the levels of testing in a country, the IHME said.
India’s Richest Man Retools Factories to Provide FREE Oxygen to 1 in 10 COVID Patients Across Country – Goodnews Network
As India grapples with an unprecedented new wave of COVID-19, one of the country’s major companies is working round-the-clock to get free oxygen out to people in need.
Traditionally, Reliance Industries is not a manufacturer of medical-grade liquid oxygen. But over a year into the pandemic, the company—which is owned by India’s richest man Mukesh Ambani—has gone on to become the nation’s largest producer from a single location, supplying over 55,000 MT of medical-grade liquid oxygen to people since March 2020.
At its refinery-cum-petrochemical complex in Jamnagar and other facilities, Reliance is producing over 1000 MT of medical-grade liquid oxygen per day—or over 11% of India’s total production—meeting the needs of nearly every 1 in 10 patients needing the life-saving treatment across the nation.
“Nothing is more important than saving every life as India battles against a new wave of the COVID-19 pandemic,” Chairman Mukesh Ambani said in a statement.
The switch-over to producing high-purity medical grade oxygen hasn’t been too difficult for Reliance engineers—the main facility is already designed for refining and petrochemicals-grade oxygen.
That said, medical grade oxygen has to be produced in liquid form at -183°C with almost 99.5% purity, which poses extraordinary challenges and risks in production and maximizing tonnage.
The Centers for Disease Control and Prevention is allowing cruise ships to resume operations this summer, but Norwegian Cruise Line CEO Frank Del Rio says that will be unlikely given the agency’s tough requirements.
“I seriously doubt we will be able to stand up a vessel out of a U.S. port in July. August is also in jeopardy and it’s all because of the disjointed guidelines from the CDC,” Norwegian Cruise Line CEO Frank Del Rio said on CNBC’s Closing Bell. “What we received yesterday was anything but a clear path to restarting.”
The company announced international cruises will resume in July from Greece, Spain, Italy, the Dominican Republic and Jamaica.
The CDC issued technical guidance for the cruise industry last week and announced it was committed to allowing the industry to resume operations by mid-summer.
Del Rio claimed the requirements put on the cruise industry are tougher than those for any other industry.
“The unfair treatment that the industry has had to endure for over a year continues. It’s got to stop, it’s unfair, it’s un-American and certainly in contradiction with the goals set forth by President [Joe] Biden,” said Del Rio.
Study reports vitamin C inhibits SARS-CoV-2 virus main protease – News-Medical
Based on structural analysis, researchers found that vitamin C binds to 3CLpro, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease essential in viral replication. In vitro cell inhibition studies also showed vitamin C could inhibit 3CLpro, indicating a possible new antiviral treatment method.
SARS-CoV-2 is an enveloped RNA virus. Some non-structural proteins are responsible for viral replication and transcription of the viral genome. These non-structural proteins are released by two viral cysteine proteases, PLpro and Mpro (also known as 3CLpro), and these proteases have been targets for the development of antivirals.
Several inhibitors of these proteases have been investigated, but most are only slightly soluble in water. So organic solvents have to be used, which can increase their toxicity and their cost. Thus, cheap, water-soluble drugs that are readily available are needed.
Vitamin C has been known to have antiviral activity. Studies have shown it can help improve antiviral treatments. Some studies where Vitamin C was injected intravenously have shown promising results in COVID-19 treatment.
In a new study published on the bioRxiv* preprint server, researchers report the crystal structure of the complex between vitamin C and 3CLpro.
Immunosuppression in COVID-19 promotes emergence of multiple immune escape mutants – medRxiv
The recent emergence of SARS-CoV-2 variants showing increased transmissibility and immune escape is a matter of global concern. Their origin remains unclear, but intra-host virus evolution during persistent infections could be a contributing factor. Here, we studied the long-term SARS-CoV-2 infection in an immunosuppressed organ transplant recipient. Frequent respiratory specimens were tested for variant viral genomes by RT-qPCR, next-generation sequencing (NGS), and virus isolation. Late in infection, several virus variants emerged which escaped neutralization by COVID-19 convalescent and vaccine-induced antisera and had acquired genome mutations similar to those found in variants of concern first identified in UK, South Africa, and Brazil. Importantly, infection of susceptible hACE2-transgenic mice with one of the patient’s escape variants elicited protective immunity against re-infection with either the parental virus, the escape variant or the South African variant of concern, demonstrating broad immune control. Upon lowering immunosuppressive treatment, the patient-generated spike-specific neutralizing antibodies and resolved the infection. Our results indicate that immunocompromised patients are an alarming source of potentially harmful SARS-CoV-2 variants and open up new avenues for the updating of COVID-19 vaccines.
New Study Estimates More Than 900,000 People Have Died Of COVID-19 In U.S. – NPR
A new study estimates that the number of people who have died of COVID-19 in the U.S. is more than 900,000, a number 57% higher than official figures.
Worldwide, the study’s authors say, the COVID-19 death count is nearing 7 million, more than double the reported number of 3.24 million.
The analysis comes from researchers at the University of Washington’s Institute for Health Metrics and Evaluation, who looked at excess mortality from March 2020 through May 3, 2021, compared it with what would be expected in a typical nonpandemic year, then adjusted those figures to account for a handful of other pandemic-related factors.
The final count only estimates deaths “caused directly by the SARS-CoV-2 virus,” according to the study’s authors. SARS-CoV-2 is the virus that causes COVID-19.
Researchers estimated dramatic undercounts in countries such as India, Mexico and Russia, where they said the official death counts are some 400,000 too low in each country. In some countries — including Japan, Egypt and several Central Asian nations — the Institute for Health Metrics and Evaluation’s death toll estimate is more than 10 times higher than reported totals.
New COVID Variant Found in Florida As State Reports Over 10,000 ‘Variant of Concern’ Cases – Newsweek
A new COVID variant of concern (VOC) has been detected in Florida, according to the state’s Department of Health.
The VOC—dubbed P2 or P.1.1—is a mutation of the variant first detected in Brazil called P1 that is more transmissible and appears to have a higher risk of reinfecting people that have already contracted the original virus.
Officials have so far identified two cases of the P2 variant in Florida—a 74-year-old man in Broward County and a 51-year-old woman in Duval County.
… “We have just two cases in Florida that have the extra mutation, and what that means remains to be seen,” Salemi said. “If in a month from now we go from two cases to 500, that will be concerning. We don’t know if new mutations are going to make current variants more or less aggressive, which is why we have people around the world actively monitoring them.”
Florida has more COVID cases caused by variants than anywhere else in the U.S. In fact, state health officials reported in Wednesday that more than 11,800 cases involving variants of concern had been recorded in the state.
Here’s how the pandemic has affected India – CNN
Delhi, Goa and Lakshwadeep are among the worst affected states and union territories in India. They are all reporting more than one new Covid-19 case per 1,000 people per day. That’s 10 times the global average of one in 10,000.
The following are foreign headlines with hyperlinks to the posts
WHO grants Chinese vaccine Sinopharm emergency use authorization
Contamination at a Baltimore vaccine manufacturer is slowing the pace of shots in Canada, Europe and South Africa.
Japan set to extend virus emergency in Tokyo through May 31
EU leaders attend summit in person for 1st time this year
Yesterday, the EU said it’s “ready to discuss” waiving patent protections for Covid vaccines. Their newfound open-mindedness follows Wednesday’s about-face from the Biden administration, which threw its support behind a waiver in order to boost vaccine manufacturing around the world. Moderna already said it won’t enforce patent rights on its mRNA vaccine, but is willing to license the technology. Pfizer’s CEO opposes a waiver.
Locked down during Cambodia’s virus outbreak, people are running out of food
While the global death count for COVID-19 currently stands at 3.2 million, the actual total may be closer to 7 million, according to a report from the Institute for Health Metrics and Evaluation.
Japanese Workers Ignore Government Request to Work Remote, Return to Office
Indian Business Owners Calling for Country Lockdown Despite Impact to Them
Germany appears to have entered a new, more hopeful phase of recovery after months of struggling against a tough third wave of the coronavirus.
Norway will introduce vaccine passports starting in early June
Unaccompanied minors among Australian citizens trapped in India by travel ban
Australia to drop entry ban for citizens and permanent residents coming from India
The following additional national and state headlines with hyperlinks to the posts
Target giving out $5 coupons to shoppers who get a COVID-19 vaccine in its stores
3 Las Vegas casinos fully opening after 80% worker vaccinations
JCPenney cuts hundreds of jobs
If you get COVID or any other illness at the Magic Kingdom, Disney (via AdventHealth) has you covered.
A new study, released as a preprint on the medRxiv* server, suggests that infants may not be as resistant to the virus as children are.
Novavax Vaccine Shows 51% Efficacy Against South African Variant, Study Finds
CDC Official Who Warned Americans Coronavirus Could Cause ‘Severe’ Disruption Resigns
More than half of Americans support vaccine passports for flying, large crowds: poll
Montana, South Carolina to kick people off jobless benefits even as unemployment rises
Greg Iacurci31 MIN AGO
Today’s Posts On Econintersect Showing Impact Of The Pandemic With Hyperlinks
30 April 2021 ECRI’s WLI Growth Rate Marginally Improves
March 2021 Headline Wholesale Sales Improved and Inventories Grow
How L.A.’s Container Ship Logjam Highlights Larger Pandemic Supply-Chain Issues
April 2021 BLS Jobs Situation – Job Gains Disappoint
Rail Week Ending 01 May 2021 – Growth Surge Over Lockdown One Year Ago
Warning to Readers
The amount of politically biased articles on the internet continues. And studies and opinions of the experts continue to contradict other studies and expert opinions. Honestly, it is difficult to believe anything anymore.
I assemble this coronavirus update daily – sifting through the posts on the internet. I try to avoid politically slanted posts (mostly from CNN, New York Times, and the Washington Post) and can usually find unslanted posts on that subject from other sources on the internet. I wait to publish posts on subjects that I cannot validate across several sources. But after all this extra work, I do not know if I have conveyed the REAL facts. It is my job to provide information so that you have the facts necessary – and then it is up to readers to draw conclusions.
Analyst Opinion of Coronavirus Data
There are several takeaways that need to be understood when viewing coronavirus statistical data:
- The global counts are suspect for a variety of reasons including political. Even the U.S. count has issues as it is possible that as much as half the population has had coronavirus and was asymptomatic. It would be a far better metric using a random sampling of the population weekly. In short, we do not understand the size of the error in the tracking numbers.
- Just because some of the methodology used in aggregating the data in the U.S. is flawed – as long as the flaw is uniformly applied – you establish a baseline. This is why it is dangerous to compare two countries as they likely use different methodologies to determine who has (and who died) from coronavirus.
- COVID-19 and the flu are different but can have similar symptoms. COVID-19 so far is much more deadly than the flu. [click here to compare symptoms]
- From an industrial engineering point of view, one can argue that it is best to flatten the curve only to the point that the health care system is barely able to cope. This solution only works if-and-only-if one can catch this coronavirus once and develops immunity. In the case of COVID-19, herd immunity may need to be in the 80% to 85% range. WHO warns that few have developed antibodies to COVID-19 when recovering from COVID-19. Herd immunity does not look like an option without immunization although there is now a discussion of whether T-Cells play a part in immunity [which means one might have immunity without antibodies]
- Older population countries will have a significantly higher death rate as there is relatively few hospitalizations and deaths in younger age groups..
- There are at least 8 strains of the coronavirus. California and New York may have a deadlier strain imported from Europe, compared to less deadly viruses elsewhere in the United States.
What we do or do not know about the coronavirus [actually there is little scientifically proven information]. Most of our knowledge is anecdotal, from studies with limited subjects, or from studies without peer review.
- How many people have been infected as many do not show symptoms?
- Masks do work. Unfortunately, early in the pandemic, many health experts — in the U.S. and around the world — decided that the public could not be trusted to hear the truth about masks. Instead, the experts spread a misleading message, discouraging the use of masks.
- Current thinking is that we develop at least 12 months of immunity from further COVID infection.
- The Moderna and Pfizer vaccines have an effectiveness rate of about 95 percent after two doses. That is on par with the vaccines for chickenpox and measles. The 95 percent number understates the effectiveness as it counts anyone who came down with a mild case of Covid-19 as a failure.
- To what degree do people who never develop symptoms contribute to transmission? Research early in the pandemic suggested that the rate of asymptomatic infections could be as high as 81%. But a meta-analysis, which included 13 studies involving 21,708 people, calculated the rate of asymptomatic presentation to be 17%.
- The accuracy of rapid testing is questioned – and the more accurate test results are not being given in a timely manner.
- Can children widely spread coronavirus? [current thinking is that they are a minor source of the pandemic spread]
- Why have some places avoided big coronavirus outbreaks – and others hit hard?
- Air conditioning contributes to the pandemic spread.
- It appears that there is increased risk of infection and mortality for those living in larger occupancy households.
- Male patients have almost three times the odds of requiring intensive treatment unit (ITU) admission compared to females.
- Outdoor activities seem to be a lower risk than indoor activities.
Treatments with solid scientific support:
- Dexamethasone
- Proning, or turning someone on their stomach
- Remdesivir
- Baricitinib
Treatments with potential but limited evidence:
- ECMO, or extracorporeal membrane oxygenation
- fluvoxamine
- Cyclosporine
- Famotidine
- Intravenous immunoglobulin
- Ivermectin
- Interferons
Drugs shown to be ineffective:
- The combination of lopinavir-ritonavir
- Hydroxychloroquine
- Insulin
- High dose zinc and vitamin C
- Convalescent plasma
- Monoclonal antibodies
- Tocilizumab
- Anti-coagulants
- A current scientific understanding of the way the coronavirus works can be found [here].
There is now a vaccine available – the questions remain:
- will there be any permanent side effects that will appear months from now,
- how long immunity will last [we can currently say we do not know if it will last more than 4 months],
- there is no solid evidence yet the vaccine will block transmission
Heavy breakouts of coronavirus have hit farmworkers. Farmworkers are essential to the food supply. They cannot shelter at home. Consider:
- they have high rates of respiratory disease [occupational hazard]
- they travel on crowded buses chartered by their employers
- few have health insurance
- they cannot social distance and live two to four to a room – and they eat together
- some reports say half are undocumented
- they are low paid and cannot afford not to work – so they will go to work sick
- they do not have access to sanitation when working
- a coronavirus outbreak among farmworkers can potentially shutter entire farm
The bottom line is that COVID-19 so far has been shown to be much more deadly than the data on the flu. Using CDC data, the flu has a mortality rate between 0.06 % and 0.11 % Vs. the coronavirus which to date has a mortality rate of 4 % [the 4% is the average of overall statistics – however in the last few months it has been hovering around 1.0%] – which makes it between 10 and 80 times more deadly. The reason for ranges:
Because influenza surveillance does not capture all cases of flu that occur in the U.S., CDC provides these estimated ranges to better reflect the larger burden of influenza.
There will be a commission set up after this pandemic ends to find fault [it is easy to find fault when a once-in-a-lifetime event occurs] and to produce recommendations for the next time a pandemic happens. Those that hate President Trump will conclude the virus is his fault.
Resources:
- Get the latest public health information from CDC: https://www.coronavirus.gov .
- Get the latest research from NIH: https://www.nih.gov/coronavirus.
- Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/.
- List of studies: https://icite.od.nih.gov/covid19/search/#search:searchId=5ee124ed70bb967c49672dad
include(“/home/aleta/public_html/files/ad_openx.htm”); ?>